CB41465-25 - 0x000000000000654B
Males & Females of Non-Childbearing Potential
Ginger
* Stipend may pay up to reflected amount.
Start Date:
April 23, 2025 - 9:15am
End Date:
May 23, 2025 - 8:30am
Study Details
Study Number: CB41465
Group Number: 25
Study Requirement: Healthy Normal Male and Female
Stipend: up to $8,000.00
Study Criteria
Age: 18 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat nausea and vomiting.
Route of Administration: Injection subcutaneous
Blood Draws: 36
Study Schedule
Schedule Type: Short stays with returns
Study Length: 10 Night Stay & 2 Returns
Screening Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 4/3/2025 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 4/3/2025 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Wednesday | 4/23/2025 9:15:00 AM | Saturday | 5/3/2025 8:45:00 AM | 1 | Phoenix |
| Return | Thursday | 5/8/2025 7:30:00 AM | Thursday | 5/8/2025 8:30:00 AM | 1 | Phoenix |
| Return | Friday | 5/23/2025 7:30:00 AM | Friday | 5/23/2025 8:30:00 AM | 1 | Phoenix |
